JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB214

Anti-Mre11 antibody [12D7] - BSA and Azide free

5

(10 Reviews)

|

(107 Publications)

Mouse Monoclonal MRE11 antibody. Carrier free. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 107 publications. Immunogen corresponding to Synthetic Peptide within Human MRE11 aa 150 to C-terminus.

View Alternative Names

HNGS1, MRE11A, MRE11, Double-strand break repair protein MRE11, Meiotic recombination 11 homolog 1, Meiotic recombination 11 homolog A, MRE11 homolog 1, MRE11 homolog A

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)

Immunocytochemical analysis of, 4% paraformaldehyde-fixed at RT for 15 min, HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling Mre-11 (green) with ab214 at 1/200 dilution. Blue : Hoechst 33342 staining. Scale bar= 10 μm.

Flow Cytometry - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)

Overlay histogram showing HeLa cells stained with ab214 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab214, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was a goat anti-mouse DyLight® 488 (IgG, H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

This image was generated using the ascites version of the product.

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
  • WB

Supplier Data

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)

Samples were separated by 7.5% SDS-PAGE.

All lanes:

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (ab214) at 1/1000 dilution

Lane 1:

293T whole cell extracts at 30 µg

Lane 2:

A431 whole cell extracts at 30 µg

Secondary

All lanes:

HRP-conjugated anti-mouse IgG antibody

false

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
  • WB

Supplier Data

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)

Samples were separated by 7.5% SDS-PAGE.

All lanes:

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (ab214) at 1/1000 dilution

Lane 1:

U87-MG whole cell extracts at 30 µg

Lane 2:

SK-N-SH whole cell extracts at 30 µg

Lane 3:

IMR32 whole cell extracts at 30 µg

Lane 4:

SK-N-AS whole cell extracts at 30 µg

Secondary

All lanes:

HRP-conjugated anti-mouse IgG antibody

false

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
  • WB

Supplier Data

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)

This image was generated using the ascites version of the product.

7.5% SDS-PAGE

All lanes:

Western blot - Anti-Mre11 antibody [12D7] - BSA and Azide free (ab214) at 1/1000 dilution

Lane 1:

HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 30 µg

Lane 2:

Human Mre-11-transfected HEK-293T whole cell lysate at 30 µg

Secondary

All lanes:

anti-mouse IgG HRP-conjugated antibody

Predicted band size: 80 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
  • ICC/IF

CiteAb

Immunocytochemistry/ Immunofluorescence - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)

Immunocytochemistry-immunofluorescence using Anti-Mre11 antibody [12D7] - BSA and Azide free, ab214. Publication image from Bohr, V. A. et al., 2016, Nat Commun, 27922005. Legend direct from paper.

WRN inhibits the recruitment of MRE11 and CtIP to DSBs.(a) Confocal microphotographs showing cell cycle independent recruitment of WRN to laser-induced DSBs in U2OS cells. Graph represents data from >200 cells. gH2AX; gamma H2AX. (b) WRN depletion increases MRE11 recruitment to DSBs in G1 cells. siRNA transfected U2OS cells were microirradiated and immunostained for cyclin A2, WRN and MRE11. Graph indicates MRE11 recruitment to laser-induced DSBs in control and WRN siRNA transfected S/G2 and G1 cells. n; number of cells. (c) WRN knockdown promotes CtIP recruitment to laser-induced DSBs. Control (siC) and WRN knockdown U2OS cells were microirradiated to generate DSBs and immunostained with WRN, CtIP and cyclin A2 antibodies. Cyclin A2 positive cells indicate cells in S/G2 phase. (d) Quantitation of CtIP and WRN signals at DSBs as seen in panel E. n=26 cells per set (e) Recruitment kinetics of mCherry-WRN and YFP-MRE11 to laser-induced DSBs in U2OS cells. n=14 cells (f) Real-time recruitment of YFP-MRE11 to laser-induced DSBs in WS cells, AG11395, expressing no WRN (vector control) and mCherry-WRN. n=28 cells (g) Recruitment of GFP-CtIP to laser-induced DSBs in AG11395 WS cells transfected with or without mCherry WRN. n=22 cells. Yellow arrow heads in panel A, B and C indicate laser-induced DSB tracks. a.u., arbitrary unit.

Other - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)
  • Other

CiteAb

Other - Anti-Mre11 antibody [12D7] - BSA and Azide free (AB214)

Proximity Ligation Assay using Anti-Mre11 antibody [12D7] - BSA and Azide free, ab214. Publication image from Nieminuszczy, J. et al., 2019, Mol Cell, 31255466. Legend direct from paper.

EXD2 Is Recruited to Stressed Replication Forks(A) Western blot of iPOND samples. Thymidine chase analysis illustrates that EXD2 specifically associates with the replisome. PCNA acts as a control.(B) Schematic of the proximity ligation assay (PLA) employed to detect colocalization of target proteins with nascent DNA.(C) Percentage of cells with MRE11/biotin PLA foci (mean ± SEM, n = 3 independent experiments, t test). Right : representative images of PLA foci (red), DAPI acts as a nuclear counterstain. Scale bar, 10 µm.(D) Percentage of cells with GFP/biotin PLA foci (mean ± SEM, n = 3 independent experiments, t test) in U2OS control cells and U2OS cells expressing GFP-EXD2. Right : representative images of PLA foci (red), DAPI acts as a nuclear counterstain. Scale bar, 10 µm.(E) Laser microirradiation induces rapid redistribution of GFP-EXD2 to damaged chromatin; representative images showing GFP-EXD2 accumulation at laser-generated DNA lesions. GFP-CtIP was used as a positive control. Scale bar, 10 µm.(F) Quantification of GFP-EXD2 (left panel) and GFP-CtIP (right panel) recruitment kinetics (intensity versus time) to laser-generated DNA lesions (mean ± SE, n ≥ 10 cells from 2 independent experiments).

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

12D7

Isotype

IgG1

Light chain type

kappa

Carrier free

Yes

Reacts with

Human

Applications

WB, IP, Flow Cyt, ICC/IF

applications

Immunogen

Synthetic Peptide within Human MRE11 aa 150 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P49959

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p>For normal lymphoblastoid cell lines.</p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1-2 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p>(see Robinson et al).</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/1000", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p>For normal lymphoblastoid cell lines.</p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p>For normal lymphoblastoid cell lines.</p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p>(see Robinson et al).</p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 10th April 2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Mre11 protein also known as MRE11A serves as an integral part of the DNA repair machinery in cells. It forms a component of the MRE11/RAD50/NBS1 (MRN) complex which is essential for the detection and repair of DNA double-strand breaks (DSBs). The molecular weight of the Mre11 protein is approximately 81 kDa. It is broadly expressed in various human tissues highlighting its extensive role in maintaining genomic stability.
Biological function summary

This protein acts in the repair of DSBs by initiating homologous recombination and non-homologous end joining pathways. Together with the RAD50 and NBS1 proteins Mre11 forms the MRN complex which processes DNA ends and signals to other repair mechanisms. Additionally Mre11's exonuclease and endonuclease activities are important for the resection of DNA at break sites facilitating subsequent repair synthesis.

Pathways

Mre11 is instrumental in the DNA damage response and maintenance of genomic integrity. It operates within the ATM (ataxia-telangiectasia mutated) signaling pathway which activates upon DNA damage and regulates cell cycle checkpoints. Mre11 interacts with the ATM protein modifying the cellular response to DNA damage. The complex also collaborates closely with BRCA1 an important regulator of the repair process and associated with preventing breast cancer development.

Mutations or dysfunction in the MRE11A gene can be linked to several conditions including ataxia-telangiectasia-like disorder (ATLD) and Nijmegen breakage syndrome (NBS). These disorders result from impaired DNA repair mechanisms leading to increased sensitivity to radiation and predisposition to cancer. The NBS1 protein as part of the MRN complex works closely with Mre11 in these conditions. Both disorders highlight the critical role of Mre11 in safeguarding genomic stability and preventing disease.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Core component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis (PubMed : 11741547, PubMed : 14657032, PubMed : 22078559, PubMed : 23080121, PubMed : 24316220, PubMed : 26240375, PubMed : 27889449, PubMed : 28867292, PubMed : 29670289, PubMed : 30464262, PubMed : 30612738, PubMed : 31353207, PubMed : 37696958, PubMed : 38128537, PubMed : 9590181, PubMed : 9651580, PubMed : 9705271). The MRN complex is involved in the repair of DNA double-strand breaks (DSBs) via homologous recombination (HR), an error-free mechanism which primarily occurs during S and G2 phases (PubMed : 24316220, PubMed : 28867292, PubMed : 31353207, PubMed : 38128537). The complex (1) mediates the end resection of damaged DNA, which generates proper single-stranded DNA, a key initial steps in HR, and is (2) required for the recruitment of other repair factors and efficient activation of ATM and ATR upon DNA damage (PubMed : 24316220, PubMed : 27889449, PubMed : 28867292, PubMed : 36050397, PubMed : 38128537). Within the MRN complex, MRE11 possesses both single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity (PubMed : 11741547, PubMed : 22078559, PubMed : 24316220, PubMed : 26240375, PubMed : 27889449, PubMed : 29670289, PubMed : 31353207, PubMed : 36563124, PubMed : 9590181, PubMed : 9651580, PubMed : 9705271). After DSBs, MRE11 is loaded onto DSBs sites and cleaves DNA by cooperating with RBBP8/CtIP to initiate end resection (PubMed : 27814491, PubMed : 27889449, PubMed : 30787182). MRE11 first endonucleolytically cleaves the 5' strand at DNA DSB ends to prevent non-homologous end joining (NHEJ) and licence HR (PubMed : 24316220). It then generates a single-stranded DNA gap via 3' to 5' exonucleolytic degradation to create entry sites for EXO1- and DNA2-mediated 5' to 3' long-range resection, which is required for single-strand invasion and recombination (PubMed : 24316220, PubMed : 28867292). RBBP8/CtIP specifically promotes the endonuclease activity of MRE11 to clear protein-DNA adducts and generate clean double-strand break ends (PubMed : 27814491, PubMed : 27889449, PubMed : 30787182). MRE11 endonuclease activity is also enhanced by AGER/RAGE (By similarity). The MRN complex is also required for DNA damage signaling via activation of the ATM and ATR kinases : the nuclease activity of MRE11 is not required to activate ATM and ATR (PubMed : 14657032, PubMed : 15064416, PubMed : 15790808, PubMed : 16622404). The MRN complex is also required for the processing of R-loops (PubMed : 31537797). The MRN complex is involved in the activation of the cGAS-STING pathway induced by DNA damage during tumorigenesis : the MRN complex acts by displacing CGAS from nucleosome sequestration, thereby activating it (By similarity). In telomeres the MRN complex may modulate t-loop formation (PubMed : 10888888).. MRE11 contains two DNA-binding domains (DBDs), enabling it to bind both single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA).
See full target information MRE11

Publications (107)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:7214 PubMed40764480

2025

The RING finger E3 ligase RNF25 protects DNA replication forks independently of its canonical roles in ubiquitin signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Lilly F Chiou,Gaith N Droby,Deepika Jayaprakash,Jay R Anand,Xingyuan Zhang,Yang Yang,C Allie Mills,Thomas S Webb,Natalie K Barker,Jialiu Xie,Di Wu,Laura E Herring,Junya Tomida,Jessica L Bowser,Cyrus Vaziri

iScience 28:112624 PubMed40546945

2025

Real-time genome imaging of host interactions in adeno-associated virus genome release.

Applications

Unspecified application

Species

Unspecified reactive species

Luisa F Bustamante-Jaramillo,Lei Yue,Joshua Fingal,Gustaf Rydell,Maria Johansson,Tomas Edreira,Oliver J Müller,Susanne Hille,Martin Müller,Franck Gallardo,Qingxin Chen,Marie-Lise Blondot,Michael Kann

Nucleic acids research 53: PubMed40479710

2025

Genome rearrangements induced by the stimulation of end-joining of DNA double strand breaks through multiple phosphorylation of MRE11 by the kinase PKB/AKT1.

Applications

Unspecified application

Species

Unspecified reactive species

Josée Guirouilh-Barbat,Iman Litchy Boueya,Camille Gelot,Gaëlle Pennarun,Christine Granotier-Beckers,Elodie Dardillac,Wei Yu,Chloé Lescale,Emilie Rass,Olivier Ariste,Nicolas Siaud,Benjamin Renouf,Armel Millet,Nadine Puget,Pascale Bertrand,Pierre de la Grange,Erika Brunet,Ludovic Deriano,Bernard S Lopez

Oncotarget 16:362-378 PubMed40387816

2025

PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Reem Ali,Mashael Algethami,Amera Sheha,Shatha Alqahtani,Ahmad Altayyar,Ayat Lashen,Emad Rakha,Abdallah Alhaj Sulaiman,Srinivasan Madhusudan,Dindial Ramotar

Nature communications 16:4491 PubMed40368919

2025

Inherited deficiency of DIAPH1 identifies a DNA double strand break repair pathway regulated by γ-actin.

Applications

Unspecified application

Species

Unspecified reactive species

Beth L Woodward,Sudipta Lahiri,Anoop S Chauhan,Marcos Rios Garcia,Lucy E Goodley,Thomas L Clarke,Mohinder Pal,Angelo Agathanggelou,Satpal S Jhujh,Anil N Ganesh,Fay M Hollins,Valentina Galassi Deforie,Reza Maroofian,Stephanie Efthymiou,Andrea Meinhardt,Christopher G Mathew,Michael A Simpson,Heather C Mefford,Eissa A Faqeih,Sergio D Rosenzweig,Stefano Volpi,Gigliola Di Matteo,Caterina Cancrini,Annarita Scardamaglia,Fiona Shackley,E Graham Davies,Shahnaz Ibrahim,Peter D Arkwright,Maha S Zaki,Tatjana Stankovic,A Malcolm R Taylor,Antonina J Mazur,Nataliya Di Donato,Henry Houlden,Eli Rothenberg,Grant S Stewart

Molecular biology of the cell 36:ar11 PubMed39705374

2024

MRE11-independent effects of Mirin on mitochondrial DNA integrity and cellular immune responses.

Applications

Unspecified application

Species

Unspecified reactive species

Koit Aasumets,Anu Hangas,Georgios Fragkoulis,Cyrielle P J Bader,Direnis Erdinc,Sjoerd Wanrooij,Paulina H Wanrooij,Steffi Goffart,Jaakko L O Pohjoismäki

Nucleic acids research 52:8320-8331 PubMed38917325

2024

MRNIP limits ssDNA gaps during replication stress.

Applications

Unspecified application

Species

Unspecified reactive species

Laura G Bennett,Ellen G Vernon,Vithursha Thanendran,Caryl M Jones,Amelia Gamble,Christopher J Staples

iScience 27:108925 PubMed38323009

2024

RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew E Randolph,Marwa Afifi,Aparna Gorthi,Rachel Weil,Breelyn A Wilky,Joshua Weinreb,Paul Ciero,Natalie Ter Hoeve,Paul J van Diest,Venu Raman,Alexander J R Bishop,David M Loeb

Nature communications 14:7882 PubMed38036565

2023

CaMKK2 and CHK1 phosphorylate human STN1 in response to replication stress to protect stalled forks from aberrant resection.

Applications

Unspecified application

Species

Unspecified reactive species

Rishi Kumar Jaiswal,Kai-Hang Lei,Megan Chastain,Yuan Wang,Olga Shiva,Shan Li,Zhongsheng You,Peter Chi,Weihang Chai

International journal of molecular sciences 24: PubMed37446144

2023

Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade.

Applications

Unspecified application

Species

Unspecified reactive species

Adel Alblihy,Reem Ali,Mashael Algethami,Alison A Ritchie,Ahmed Shoqafi,Shatha Alqahtani,Katia A Mesquita,Michael S Toss,Paloma Ordóñez-Morán,Jennie N Jeyapalan,Lodewijk Dekker,Martina Salerno,Edgar Hartsuiker,Anna M Grabowska,Emad A Rakha,Nigel P Mongan,Srinivasan Madhusudan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com